Private Capital Group, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Private Capital Group, LLC holds 151 shares of BHVN stock, worth $7,701. This represents 0.02% of its overall portfolio holdings.
Number of Shares
151
Previous 111
36.04%
Holding current value
$7,701
Previous $13,000
69.23%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BHVN
# of Institutions
11Shares Held
785KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL710KShares$36.2 Million16.66% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$1.83 Million0.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$967,9803.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$589,5600.16% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$375,6150.25% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $3.65B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...